Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-07-16, Stock:JNJ, The news for the past five days is as follows:
2020-07-09: NEWS1: Health Giant Johnson & Johnson On Deck To Report — Here's What We Know.NEWS2: Dividend Tide Turns, Barring a Second Wave. Here’s How to Avoid a Wipeout..NEWS3: Coronavirus update: Florida sees deadliest day yet as US cases spike, economy jitters grow.NEWS4: U.S. planning for tens of millions of potential COVID-19 vaccine doses this fall - official.NEWS5: Johnson & Johnson (JNJ) Expected to Beat Earnings Estimates: Should You Buy?.NEWS6: Coronavirus vaccine makers to testify before U.S. House committee.NEWS7: 3 Stocks I'll Be Buying When the Market Crashes Again.NEWS8: Prominent plaintiffs' firms sought government bailout to stay afloat.NEWS9: Nonprofits urge Johnson & Johnson to halt sales of Baby Powder globally.
2020-07-10: NEWS1: A Safer Way to Play IBio Stock Could Spread Like the Coronavirus.NEWS2: INO Stock Could Receive Operation Warp Speed Funding Soon.NEWS3: FDA says to review side effect of GSK's multiple myeloma drug.NEWS4: Britain to set out its position on EU vaccine scheme later on Friday.
2020-07-13: NEWS1: Roche Forecasted to Be Top Drug Seller in 2026.NEWS2: Pfizer, UnitedHealth share gains lead Dow's 25-point jump.NEWS3: Bad Breath Offers a Rare Payoff in Listerine-Royalty Stake Sale.NEWS4: Gartner’s Annual Supply Chain Ranking Reflects Historic Disruption Of 2020.NEWS5: Dow up nearly 300 points on gains in Pfizer, Apple Inc. shares.NEWS6: J&J (JNJ) to Kickstart Q2 Earnings for the Pharma Sector.
2020-07-14: NEWS1: New Products, Expanded Indications Drive Sales of Top 5 Pharmas.NEWS2: FDA panel votes in favor of approving GSK's multiple myeloma drug.NEWS3: Race to Coronavirus Vaccine Heats Up: 5 Stocks in Spotlight.
2020-07-15: NEWS1: Trading Johnson & Johnson Once It Reports Earnings.NEWS2: J&J's Tremfya Receives FDA Approval for Psoriatic Arthritis.NEWS3: Johnson & Johnson Is Poised (Again) for an Upside Breakout.NEWS4: Markets open higher on COVID-19 vaccine hopes.NEWS5: Why Earnings Season Could Be Great for Johnson & Johnson (JNJ).NEWS6: The Zacks Analyst Blog Highlights: Pfizer, BioNTech, Moderna, Novavax and Johnson & Johnson.NEWS7: The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent.

Answer: Rise